Prismic Pharmaceuticals Inc is categorized under in Scottsdale, AZ and active since 2011.
Prismic Pharmaceuticals Inc was established in 2011, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Peter Moriarty, Chief Executive Officer at the company’s single location by writing to 8283 North Hayden Road # 270, Scottsdale, Arizona AZ 85258 or by phoning (480) 422-1813. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Prismic Pharmaceuticals Inc |
Contact Person: | Peter Moriarty, Chief Executive Officer |
Address: | 8283 North Hayden Road # 270, Scottsdale, Arizona 85258 |
Phone Number: | (480) 422-1813 |
Website Address: | prismicpharma.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | |
SIC Code: | 2834 |
NAICS Code: | 3254120 |
Share This Business: |
Prismic Pharmaceuticals Inc was started in 2011 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Peter Moriarty, Chief Executive Officer for inquiries that concern Prismic Pharmaceuticals Inc by calling the company number (480) 422-1813, as your correspondence is most welcome. Additionally, the physical location of the single location of Prismic Pharmaceuticals Inc can be found at the coordinates 33.556572,-111.898622 as well as the street address 8283 North Hayden Road # 270 in Scottsdale, Arizona 85258.
For its online presence, you may visit Prismic Pharmaceuticals Inc’s website at prismicpharma.com and engage with its social media outlets through on Twitter and on Facebook.